Curcumin in solid organ transplantation: current evidence, mechanisms, and translational challenges
- 1Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi Medical University
- 2Key Laboratory of Oral Disease Research of the Education Department of Guizhou Province, Stomatology Hospital of Zunyi Medical University
Abstract
Solid organ transplantation faces complex pathophysiological challenges, including ischemia-reperfusion injury (IRI), alloimmune rejection, and chronic graft dysfunction. These interconnected processes involve multiple signaling pathways, yet these complex interconnected pathological processes remain a significant clinical challenge. In contrast, natural plant-derived compounds often possess pleiotropic pharmacological activities and may offer a multi-targeted approach to modulate the overall pathological milieu. Curcumin, a representative bioactive natural polyphenol from Curcuma longa , exhibits potent antioxidant, anti-inflammatory, and immunomodulatory properties and has shown therapeutic benefits across a wide range of diseases. In the context of transplantation, preliminary studies have demonstrated encouraging effects in improving graft preservation, attenuating injury, and modulating immune response. However, direct investigation of curcumin in solid organ transplantation remains limited, with fragmented evidence and a weak foundational basis. This review aims to systematically synthesize the current evidence for curcumin’s application in kidney, liver, heart, and lung transplantation, to assess the translational hurdles, and to propose a strategic roadmap for future research. We also propose a mechanistic framework for curcumin’s potential actions based on established studies in related fields, including IRI, inflammatory diseases, and immunology, intended to generate testable hypotheses for future transplant-focused research. By identifying key knowledge gaps and highlighting promising mechanistic pathways, we hope to stimulate further investigation and accelerate the clinical translation of this pleiotropic natural compound into transplant medicine.
Related
- Herbal-derived bioactive compounds in stroke recovery: from neuroprotective mechanisms to clinical evidence and translational challenges
- Targeting the gut microbiota to promote motor rehabilitation after spinal cord injury: mechanisms, evidence, and translational challenges
- Polydeoxyribonucleotide (PDRN) in Osteoarthritis: Immunomodulatory and Matrix-Supportive Potential, A2A Receptor-Associated Mechanisms, and Translational Challenges
- Cellular immunotherapy for lung cancer: current clinical evidence, translational challenges, and future perspectives: a narrative review
- Advanced cell-laden hydrogels for diabetic wound healing: Biomaterial design, therapeutic mechanisms, and translational challenges
BibTeX
@article{liang2026curcumin,
title = {{Curcumin in solid organ transplantation: current evidence, mechanisms, and translational challenges}},
author = {Lubiao Liang and Wei Xiong and Chunyang Guo and Yongxiang Song and Yajin Zhao},
journal = {Frontiers in Pharmacology},
year = {2026},
month = oct,
doi = {10.3389/fphar.2026.1911685},
url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1911685/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Curcumin in solid organ transplantation: current evidence, mechanisms, and translational challenges
AU - Lubiao Liang
AU - Wei Xiong
AU - Chunyang Guo
AU - Yongxiang Song
AU - Yajin Zhao
PY - 2026
DA - 2026/10/08
JO - Frontiers in Pharmacology
DO - 10.3389/fphar.2026.1911685
UR - https://www.frontiersin.org/articles/10.3389/fphar.2026.1911685/full
AB - Solid organ transplantation faces complex pathophysiological challenges, including ischemia-reperfusion injury (IRI), alloimmune rejection, and chronic graft dysfunction. These interconnected processes involve multiple signaling pathways, yet these complex interconnected pathological processes remain a significant clinical challenge. In contrast, natural plant-derived compounds often possess pleiotropic pharmacological activities and may offer a multi-targeted approach to modulate the overall pathological milieu. Curcumin, a representative bioactive natural polyphenol from Curcuma longa , exhibits potent antioxidant, anti-inflammatory, and immunomodulatory properties and has shown therapeutic benefits across a wide range of diseases. In the context of transplantation, preliminary studies have demonstrated encouraging effects in improving graft preservation, attenuating injury, and modulating immune response. However, direct investigation of curcumin in solid organ transplantation remains limited, with fragmented evidence and a weak foundational basis. This review aims to systematically synthesize the current evidence for curcumin’s application in kidney, liver, heart, and lung transplantation, to assess the translational hurdles, and to propose a strategic roadmap for future research. We also propose a mechanistic framework for curcumin’s potential actions based on established studies in related fields, including IRI, inflammatory diseases, and immunology, intended to generate testable hypotheses for future transplant-focused research. By identifying key knowledge gaps and highlighting promising mechanistic pathways, we hope to stimulate further investigation and accelerate the clinical translation of this pleiotropic natural compound into transplant medicine.
SN - 1663-9812
ER -